Amphastar Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Amphastar Pharmaceuticals patents 2 in total

Status Patent
Application
Utility: HIGHLY PURIFIED RECOMBINANT HUMAN INSULIN (RHI) API AND METHODS OF PRODUCING THE SAME External link
Filling date: 6 Sep 2025 Issue date: 9 Jul 2020
Application
Utility: HIGH-PURITY INHALABLE PARTICLES OF INSULIN AND INSULIN ANALOGUES, AND HIGH-EFFICIENCY METHODS OF MANUFACTURING THE SAME External link
Filling date: 6 Sep 2025 Issue date: 26 Dec 2019

Showing 1 to 2 of 2 patents.